This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Southern California. Active years: 2020-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2023
Title: Innovator Sheng-Fang Su: Pioneering DNA Methylation Biomarkers for Bladder Cancer
Introduction
Sheng-Fang Su is an accomplished inventor based in Los Angeles, CA, recognized for his significant contributions to the field of cancer diagnostics. With a total of two patents, Su has developed innovative methods that enhance the prediction, prognosis, and diagnosis of bladder cancer, showcasing his dedication to advancing medical research.
Latest Patents
Sheng-Fang Su's latest patents focus on DNA methylation biomarkers for bladder cancer. These patents detail a method involving the provision of a test sample from a subject, measuring DNA methylation levels of selected polynucleotides such as HOXA9, SOX1, NPY, IRAK3, L1-MET, and ZO2. The process includes calculating a risk score based on the measured levels and comparing this score to a cut-off value derived from a reference DNA methylation profile of a control group comprising individuals with bladder cancer. The method ultimately determines whether bladder cancer has recurred, evaluates the likelihood of recurrence, and ascertains the presence of bladder cancer in patients.
Career Highlights
Currently, Sheng-Fang Su is associated with the University of Southern California, where he continues to lead research initiatives in cancer diagnostics. His dedication to innovative research has marked significant advancements in understanding cancer biology and improving patient outcomes.
Collaborations
Su has collaborated with notable colleagues, including Gangning Liang and Peter A. Jones. Together, they contribute to the evolving landscape of cancer research, leveraging their expertise to foster developments that have the potential to revolutionize cancer diagnostics and treatment strategies.
Conclusion
Sheng-Fang Su exemplifies the spirit of innovation within the medical research community. Through his patents and collaborative efforts at the University of Southern California, he is making strides in the fight against bladder cancer, ultimately aiming to improve diagnosis and treatment options for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile